1Gillis JC, Wiseman LR. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.Drugs. 1996,51(4):621～638.
2Rao PS, Shivananda PG. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents. Indian J Pathol Microbiol. 2000,43(3) :281-284.
3Videau D, Niel G, Siboulet A, Catalan F. Secnidazole. A 5-nitroimidazole derivative with a long half-life. Br J Vener Dis.1978,54(2):77-80.
4J Dupouy-Camet. Single dose treatments in tropical infectious diarrhoea: the place of secnidazole. Drug Invest. 1994,8(suppl):S35-S46.
5Lamp KC, Freeman CD, Klutman NE,et al. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet. 1999,36(5) :355-373.
6Tenenbaum H, Cuisinier FJ, Le Liboux A,et al. Secnidazole concentrations in plasma and crevicular fluid after a single oral dose.J Clin Periodontol. 1993 ,20(7) :505-508.
7Symonds J. Secnidazole a nitroimidazole with a prolonged serum half-life. J Antimicrob Chemother. 1979,5(4) :484-486.
